HS is caused by genetic defects in red blood cell membrane proteins, leading to chronic hemolysis, anemia, jaundice, splenomegaly, and fatigue. Though relatively uncommon compared to other hematologic disorders, HS requires targeted diagnostics, long-term management strategies, and supportive care, making it a specialized segment within rare disease markets. https://www.databridgemarketresearch.com/reports/global-hereditary-spherocytosis-market